期刊文献+

成人特发性膜性肾病血清抗M型磷脂酶A2受体抗体与病情的相关性研究 被引量:24

Correlation between serum anti-PLA2R antibody and adult idiopathic membranous nephropathy
在线阅读 下载PDF
导出
摘要 目的通过研究成人特发性膜性肾病(IMN)血清抗M型磷脂酶A2受体(PLA2R)抗体的阳性滴度与其他实验室指标的相关性,进一步探讨抗PLA2R抗体对IMN诊断及病情评估的作用。方法选取B超引导下肾穿刺活检证实为IMN患者55例,追踪观察6个月,同时选取15例健康体检者为对照组,应用酶联免疫吸附法(ELISA)检测血清抗PLA2R抗体,同时对IMN患者24 h尿蛋白定量、血清总蛋白、血清白蛋白、血清总胆固醇、血清肌酐进行检测。结果经过3和6个月治疗后,血清抗PLA2R抗体较治疗前降低(P<0.05)。55例IMN患者治疗前血清抗PLA2R抗体阳性患者47例,阳性率为85.45%;治疗3个月后血清抗PLA2R抗体阳性患者36例,阳性率为65.45%,治疗6个月后血清抗PLA2R抗体阳性患者25例,阳性率45.45%。且治疗前血清抗PLA2R抗体滴度与尿蛋白定量呈正相关,与血清白蛋白、总蛋白呈负相关;治疗6个月后血清抗PLA2R抗体滴度与尿蛋白定量呈正相关,与血清白蛋白、总蛋白呈负相关。结论血清抗PLA2R抗体可作为IMN血清学诊断的指标之一,血清抗PLA2R抗体滴度下降与尿蛋白的减少密切相关,与疾病预后、病情转归也可能相关。 Objective To investigate the relationship between the positive titer of serum anti- phospho-lipase A2 receptor(PLA2R) antibody and other laboratory indexes in adult patients with idiopathic membranous nephropathy(IMN), and to explore the roles of anti-PLA2 R antibody in the diagnosis of IMN and the evaluation of the disease severity. Methods Fifty-five IMN patients were selected, and 15 cases of healthy persons were selected as the control group. Serum anti-PLA2 R antibody was detected by ELISA. And 24-h urinary protein, serum total protein, serum total cholesterol and serum creatinine were detected in the IMN patients. Results After 3 months and 6 months, the serum anti-PLA2 R antibody was significantly lower than that before treatment(P〈0.05). Before treatment 47 of 55 IMN patients were anti-PLA2 R antibody positive,the positive rate was 85.45%; 3 months after the treatment there were 36 patients with positive anti-PLA2 R antibody, the positive rate was 65.45%; 6 months after treatment, anti-PLA2 R antibody positive rate was45.45%(25/55). The serum anti-PLA2 R antibody titer was positively correlated with urinary protein, but was negatively correlated with serum albumin and total protein before treatment and 6 months after treatment.Conclusions Serum anti-PLA2 R antibody can be used as one of the serum indexes of IMN, and serum antiPLA2 R antibody titer is closely related to urine protein, which may be closely related to the prognosis and outcome of the disease.
出处 《中国现代医学杂志》 CAS 北大核心 2016年第9期44-48,共5页 China Journal of Modern Medicine
关键词 特发性膜性肾病 酶联免疫反应 抗M型磷脂酶A2受体抗体 diopathic membranous nephropathy enzyme linked immune response anti-PLA2R antibody
  • 相关文献

参考文献13

  • 1WASSERSTEIN A G. Membranous glomerulonephritis[J]. J Am Soc Nephro, 1997, 8(4): 664-674.
  • 2BECK L H, BONEGIO R G, LAMBEAU G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 36(1): 11-21.
  • 3BECK L H, FERVENZA F C, BECK D M, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy[J]. JAm Soc Nephrol, 2011, 22(8): 1543-1550.
  • 4NANGAKU M, SHANKLAND S J, COUSER W G, et al. Cellular response to injury in membranous nephropathy[J]. Am Soc Nephrol, 2005, 16(5): 1195-1204.
  • 5MUNDEL P L, SHANKLAND S J. Podocyte biology and response to injury[J]. Am Soc Nephrol, 2002, 13(12): 3005-3015.
  • 6QIN W, BECK L H, ZENG C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy[J]. J Am Soc Nephrol, 2011, 22(6): 1137-1143.
  • 7韩丹诺,谌贻璞,王艳艳,董鸿瑞,芮宏亮,王国勤,程虹.特发性膜性肾病中血清磷脂酶A2受体抗体的临床意义[J].中国实用内科杂志,2015,35(4):351-354. 被引量:21
  • 8SEGARRA-MEDRANO A, JATEM-ESCALANTE E, CARNICER-CICERES C, et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus[J]. Nefrologia, 2014, 34(4): 491-497.
  • 9HOFSTRA J M, DEBIEC H, SHORT C D, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy[J]. J Am Soc Nephrol, 2012, 23(10): 1735-1743.
  • 10周广宇,金玲,于晶,张芝平.成人膜性肾病患者血清抗PLA2R抗体与病情的相关性[J].中华肾脏病杂志,2012,28(2):111-114. 被引量:63

二级参考文献19

  • 1Wasserstein AG.Membranous glomerulonephritis.J Am Soc Nephrol,1997,8:664-674.
  • 2Li LS,Liu ZH.Epidemiologic data of renal diseases from a single unit in China:analysis based on 13,519 renal biopsies.Kidney Int,2004,66:920-923.
  • 3Ponticelli C.Membranous nephropathy.J Nephrol,2007,20:268-287.
  • 4Beck LH Jr,Bonegio RG,Lambeau G,et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.N Engl J Med,2009,361:11-21.
  • 5Salant DJ,Cybulsky AV.Experimental glomerulonephritis.Methods Enzymol,1988,162:421-461.
  • 6Qin W,Beck LH Jr,Zeng C,et al.Anti-phospholipase A2 receptor antibody in membranous nephropathy.J Am Soc Nephrol,2011,22:1137-1143.
  • 7Debiec H,Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.N Engl J Med,2011,364:689-690.
  • 8Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges [J]. Nat Rev Nephrol, 2012, 8(4): 203- 213.
  • 9Glassock RJ. The pathogenesis of membranous nephropathy: evolution and revolution [J]. Curr Opin Nephrol Hypertens, 2012, 21(3): 235- 242.
  • 10Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy [J].J Am Soc Nephrol, 2014, 25(6): 1357- 1366.

共引文献75

同被引文献156

引证文献24

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部